Marilyn Elson

CIK: 0001916491

Transaction Breakdown

Open Market Buys (P)1 (10.0%)

High conviction signal

Open Market Sales (S)1 (10.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NXL

Nexalin Technology, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (10 total)

NXL
Nexalin Technology, Inc.
Sep 10, 2025
Sale(S)
Common Stock Warrants
Direct
23.2K shares at avg. $0.02-
NXL
Nexalin Technology, Inc.
Jul 17, 2025
Award(A)
Stock Option (right to buy)
Direct
150K shares-
NXL
Nexalin Technology, Inc.
Jul 17, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-
NXL
Nexalin Technology, Inc.
Jul 17, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-
NXL
Nexalin Technology, Inc.
Jul 17, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-
NXL
Nexalin Technology, Inc.
Jul 17, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-
NXL
Nexalin Technology, Inc.
Jul 17, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-
NXL
Nexalin Technology, Inc.
Sep 30, 2024
Award(A)
Direct
700K shares-
NXL
Nexalin Technology, Inc.
Sep 23, 2024
Award(A)
Direct
700K shares-
NXL
Nexalin Technology, Inc.
Sep 28, 2022
Purchase(P)
Common stock warrants
Direct
36K shares at avg. $0.40-

		Type	Shares	Price		Ownership
Sep 10, 2025	NXL Nexalin Technology, Inc.	Sale(S) Common Stock Warrants	23,150	$0.02	-	Direct
Jul 17, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	150,000	-	-	Direct
Jul 17, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Jul 17, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Jul 17, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Jul 17, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Jul 17, 2025	NXL Nexalin Technology, Inc.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Sep 30, 2024	NXL Nexalin Technology, Inc.	Award(A)	700,000	-	$0	Direct
Sep 23, 2024	NXL Nexalin Technology, Inc.	Award(A)	700,000	-	$0	Direct
Sep 28, 2022	NXL Nexalin Technology, Inc.	Purchase(P) Common stock warrants	36,000	$0.40	-	Direct

1-10 of 10 transactions

About Elson Marilyn

Elson Marilyn (SEC CIK 0001916491) files insider reports with the SEC as 10% Owner of Nexalin Technology, Inc. (NXL).

Signal8 holds 5 ownership filings by Elson Marilyn, all Form 4s, filed between Sep 25, 2024 and Sep 12, 2025. Those filings report 10 transactions, from Sep 28, 2022 to Sep 10, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Elson Marilyn's filings is in ROSELAND, NJ.

Recent filings by Elson Marilyn

Sep 10, 2025: Open-market sale of NXL derivative securities (Form 4, code S).
Jul 17, 2025: Grants or awards of NXL derivative securities (6 lines, Form 4, code A).
Sep 30, 2024: Grant or award of NXL shares (Form 4, code A).
Sep 23, 2024: Grant or award of NXL shares (Form 4, code A).
Sep 28, 2022: Open-market purchase of NXL derivative securities (Form 4, code P).

Other insiders filing for Nexalin Technology, Inc. (NXL)

White Mark, President and CEO
Van Fleet Justin, CFO
Owens David, Chief Medical Officer
Shelton Carolyn Hamby, Senior VP
Hu Ben, Director
Kazden Alan, Director

How to read Form 4 transaction codes